On May 28, 2024 Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") reported members of its executive team are scheduled to participate in the upcoming conferences, detailed below (Press release, Innate Pharma, MAY 28, 2024, View Source [SID1234643735]). Participants will include Hervé Brailly, Chief Executive Officer, Sonia Quaratino, Executive Vice President (EVP), Chief Medical Officer, Yannis Morel, EVP, Chief Operating Officer and Arvind Sood, EVP, President of US Operations.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Global Healthcare Conference
Event dates: June 5-6, 2024 | New York, United States

Goldman Sachs 45th Annual Global Healthcare Conference
Event dates: June 10-13, 2024 | Miami, United States

H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
Event date: June 25, 2024 | Virtual

Stifel 2nd European Healthcare Summit Lyon
Event dates: June 25-27, 2024 | Lyon, France